Proceedings of the Tenth International Conference of Drug Regulatory Authorities (ICDRA) - Hong Kong, China, 24 - 27 June 2002
(2002; 166 pages) View the PDF document
Table of Contents
View the documentAbbreviations and acronyms used in this report
Open this folder and view contentsOpening ceremony
Open this folder and view contentsHerbal medicines
Open this folder and view contentsKeynote address
Open this folder and view contentsSafety of blood-derived products
Close this folderAntimicrobial resistance - new initiatives
View the documentWHO’s global strategy for the containment of antimicrobial resistance
View the documentImplementing a strategy for the containment of antimicrobial resistance: experience in Uganda
View the documentVeterinary issues contributing to antimicrobial resistance
View the documentStatus of regulation of antimicrobials in Cuba
View the documentFighting antibiotic resistance in Sweden
View the documentAntimicrobial use in Chile - the impact of regulatory measures
View the documentRecommendations
Open this folder and view contentsHarmonization I
Open this folder and view contentsHarmonization II
Open this folder and view contentsProtection of trial subjects in clinical trials
Open this folder and view contentsRegulating biotechnology products
Open this folder and view contentsRegulatory challenges: health sector reform and drug regulatory capacity
Open this folder and view contentsAccess to drugs and vaccines I
Open this folder and view contentsAccess to drugs and vaccines II
Open this folder and view contentsCounterfeit pharmaceutical products
Open this folder and view contentsHomoeopathy
Open this folder and view contentsSafety monitoring
Open this folder and view contentsE-Commerce
Open this folder and view contentsCurrent topics
Open this folder and view contentsRegulatory challenges of new technologies
View the documentList of participants
View the documentBack cover
 

Antimicrobial use in Chile - the impact of regulatory measures

Dr Luis Bavestrello, Chile

A study of the consumption of antimicrobials in Chile in 1998 demonstrated a significant increase in consumption in each of the previous ten years. As a result, the Ministry of Health adopted an action plan to promote the rational use of antimicrobials. The plan included:

• restrictions on the sale of antimicrobials,
• public information provided through leaflets and posters in private pharmacies,
• an education campaign with extensive coverage,
• monitoring of compliance with restrictions on sales.


The measures had an important impact on consumption in the community, which could already be discerned in 1999, and was more marked in 2000. The following conclusions may be drawn:

• The measures contributed to a considerable saving for the population.

• A programme of rational use requires a permanent multidisciplinary approach and epidemiological monitoring.

• The impact of the regulatory measures is reflected in the short term in an impact on consumption and therefore in economic terms; the impact of the measures on resistance is seen only in the longer term.

• To succeed, there is a need for political will, public consultation and education, and effective measures.

• The success of the long-term programme depends on the maintenance, supervision and control of the measures by all involved, including physicians, prescribers, pharmacists and the community in general.

 

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: June 25, 2014